Cargando…

The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022

Cardiovascular disease (CVD) has become a huge challenge for the global public health system due to its high morbidity, mortality and severe economic burden. In recent years, angiotensin receptor neprilysin inhibitor (ARNI), a new class of drugs, has shown good therapeutic effects on CVD patients in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xia, Li, Yumeng, Shi, Shuqing, Lv, Jiayu, Wang, Yajiao, Zheng, Haoran, Mao, Xinxin, Wu, Huaqin, Zhang, Bingxuan, Song, Qingqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114353/ https://www.ncbi.nlm.nih.gov/pubmed/35600466 http://dx.doi.org/10.3389/fcvm.2022.899235

Ejemplares similares

Research trends and hotspots evolution of cardiac amyloidosis: a bibliometric analysis from 2000 to 2022
por: Fu, Zhenyue, et al.
Publicado: (2023)

SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules
por: Wang, Yajiao, et al.
Publicado: (2023)

Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
por: Shi, Shuqing, et al.
Publicado: (2022)

Blood urea nitrogen to creatinine ratio and long-term survival in patients with chronic heart failure
por: Wang, Yajiao, et al.
Publicado: (2023)

Trends in research on sick sinus syndrome: A bibliometric analysis from 2000 to 2022
por: Zhang, Xin’ai, et al.
Publicado: (2022)

Efficacy and safety of Linggui Zhugan decoction in the treatment of chronic heart failure with Yang deficiency: A protocol for systematic review and meta-analysis
por: Li, Yumeng, et al.
Publicado: (2021)

Angiotensin receptor-neprilysin inhibitor improves coronary collateral perfusion
por: Li, Kangbo, et al.
Publicado: (2023)

Effects of garlic supplementation on components of metabolic syndrome: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
por: Fu, Zhenyue, et al.
Publicado: (2023)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
por: Zhu, Tianyu, et al.
Publicado: (2022)

Research landscape of exosomes in platelets from 2000 to 2022: A bibliometric analysis
por: Zhan, Min, et al.
Publicado: (2022)

A bibliometric analysis of acute myocardial infarction in women from 2000 to 2022
por: Xu, Ming, et al.
Publicado: (2023)

Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension
por: AlSiraj, Yasir, et al.
Publicado: (2021)

Role of inflammation and immunity in vascular calcification: a bibliometric and visual analysis, 2000–2022
por: Wang, Chen, et al.
Publicado: (2023)

Transient Receptor Potential Channels, Natriuretic Peptides, and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure
por: Ding, Kun, et al.
Publicado: (2022)

Global research trends of hypertrophic cardiomyopathy from 2000 to 2022: Insights from bibliometric analysis
por: Zheng, Xifeng, et al.
Publicado: (2023)

The angiotensin receptor and neprilysin inhibitor, LCZ696, in heart failure: A meta-analysis of randomized controlled trials
por: Chen, Yan, et al.
Publicado: (2022)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications
por: Chai, Ruoning, et al.
Publicado: (2022)

Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2021)

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study
por: Williams, Bryan, et al.
Publicado: (2014)

Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
por: Chen, Yiru, et al.
Publicado: (2023)

Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023)

Angiotensin receptor-neprilysin inhibitor therapy and recurrence of atrial fibrillation after radiofrequency catheter ablation: A propensity-matched cohort study
por: Dong, Youzheng, et al.
Publicado: (2022)

Research trends in cardiovascular tissue engineering from 1992 to 2022: a bibliometric analysis
por: Lai, Ping, et al.
Publicado: (2023)

Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Retrospective Multi-Institutional Study
por: Hsiao, Fu-Chih, et al.
Publicado: (2022)

Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias
por: Sutanto, Henry, et al.
Publicado: (2021)

Efficacy of angiotensin receptor neprilysin inhibitor in Asian patients with refractory hypertension
por: Li, Wanjing, et al.
Publicado: (2022)

Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure
por: Sun, Yuxi, et al.
Publicado: (2021)

Safety of the neprilysin/renin-angiotensin system inhibitor LCZ696
por: Li, Bo, et al.
Publicado: (2017)

Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor
por: Dargad, Ramesh R., et al.
Publicado: (2018)

Narrative review in the current role of angiotensin receptor-neprilysin inhibitors
por: Cruz Rodriguez, Jose B., et al.
Publicado: (2021)

Acute Tubular Necrosis Associated with Angiotensin Receptor-neprilysin Inhibitor
por: Kim, Moo Jun, et al.
Publicado: (2021)

Bibliometric evaluation of publications on inflammasomes in atherosclerosis from 2002 to 2022
por: Tan, Yu, et al.
Publicado: (2023)

Bibliometric and visual analysis of intraoperative hypotension from 2004 to 2022
por: Wang, Jieyan, et al.
Publicado: (2023)

Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study
por: Mao, Yukang, et al.
Publicado: (2023)

Coronary heart disease and gut microbiota: A bibliometric and visual analysis from 2002 to 2022
por: Long, Dan, et al.
Publicado: (2022)

Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure
por: Dizaye, Kawa, et al.
Publicado: (2019)

A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
por: Wang, Yifei, et al.
Publicado: (2023)

Trends in mitochondrial unfolded protein response research from 2004 to 2022: A bibliometric analysis
por: Ye, Zelin, et al.
Publicado: (2023)

Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice
por: Esser, Nathalie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dln837eq12s6mruhjrbb4j5gl7